Cycrin



Indications and Reactions:

Role Indications Reactions
Primary
Hormone Replacement Therapy 85.0%
Arthritis 5.0%
Hypertension 5.0%
Menopausal Symptoms 5.0%
Breast Cancer 54.5%
Breast Cancer Female 27.3%
Deep Vein Thrombosis 9.1%
Pulmonary Embolism 9.1%
Secondary
Hormone Replacement Therapy 80.0%
Menopausal Symptoms 6.9%
Menopause 3.6%
Oestrogen Replacement Therapy 2.5%
Hypertension 1.4%
Depression 0.9%
Hormone Therapy 0.6%
Hot Flush 0.4%
Anxiety 0.4%
Diabetes Mellitus 0.4%
Blood Cholesterol Increased 0.4%
Drug Use For Unknown Indication 0.3%
Thyroid Disorder 0.3%
Osteoarthritis 0.3%
Blood Pressure 0.3%
Cardiac Disorder 0.3%
Migraine 0.3%
Gastrooesophageal Reflux Disease 0.3%
Osteoporosis 0.2%
Pain 0.2%
Breast Cancer 57.1%
Breast Cancer Female 25.5%
Breast Cancer Metastatic 8.2%
Progesterone Receptor Assay Positive 1.2%
Breast Cancer In Situ 1.2%
Ovarian Cancer 1.1%
Invasive Ductal Breast Carcinoma 0.9%
Thrombosis 0.7%
Cerebrovascular Accident 0.5%
Oestrogen Receptor Assay Positive 0.5%
Deep Vein Thrombosis 0.5%
Pulmonary Embolism 0.5%
Breast Cancer Recurrent 0.4%
Uterine Leiomyoma 0.3%
Contralateral Breast Cancer 0.3%
Ovarian Cancer Metastatic 0.3%
Tricuspid Valve Incompetence 0.3%
Depression 0.2%
Myocardial Infarction 0.2%
Breast Disorder 0.2%
Concomitant
Hormone Replacement Therapy 31.6%
Hypothyroidism 10.5%
Osteoporosis 10.5%
Menopausal Symptoms 7.0%
Osteoarthritis 5.3%
Pain 5.3%
Depression 3.5%
Hot Flashes 3.5%
Schizoaffective Disorder 3.5%
Arthralgia 1.8%
Bipolar Disorder 1.8%
Breath Odour 1.8%
Gout 1.8%
Heart Disorder 1.8%
High Cholesterol 1.8%
Hot Flush 1.8%
Nuclear Magnetic Resonance Imaging 1.8%
Osteopenia 1.8%
Product Used For Unknown Indication 1.8%
Sleep Problem 1.8%
Breast Cancer 23.3%
Breast Cancer Female 10.0%
Tendonitis 6.7%
Unevaluable Event 6.7%
Acne 3.3%
Alopecia 3.3%
Arthralgia 3.3%
Cerebrovascular Accident 3.3%
Contusion 3.3%
Diabetes Mellitus 3.3%
General Physical Health Deterioration 3.3%
Injury 3.3%
Neuropathy Peripheral 3.3%
Oropharyngeal Pain 3.3%
Pulmonary Embolism 3.3%
Renal Failure 3.3%
Skin Disorder 3.3%
Systemic Lupus Erythematosus 3.3%
Type 2 Diabetes Mellitus 3.3%
Vertebroplasty 3.3%